SGK1 up-regulates orai1 expression and VSMC migration during neointima formation after arterial injury

Thrombosis and Haemostasis

Volumn 117, Issue 5, 2017, Pages 1002-1005

  Walker Allgaier, Britta ^a   Schaub, Malte ^a   Alesutan, Ioana ^a,b,c   Voelkl, Jakob ^a,b   Geue, Sascha ^a   Münzer, Patrick ^a   Rodríguez, José M ^d   Kuhl, Dietmar ^e   Lang, Florian ^a   Gawaz, Meinrad ^a   Borst, Oliver ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BERLIN INSTITUTE OF HEALTH   (Germany)

^d ROCKEFELLER UNIVERSITY   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; IMMEDIATE EARLY PROTEIN; ORAI1 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL DIET; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LETTER; MOUSE; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ZYMOGRAPHY; ANIMAL; APOLIPOPROTEIN E KNOCKOUT MOUSE; CAROTID ARTERY INJURY; CELL CULTURE; CELL MOTION; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; IMMEDIATE-EARLY PROTEINS; MICE, KNOCKOUT, APOE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; ORAI1 PROTEIN; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 85019579546     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH16-09-0690     Document Type: Letter

References (23)

1. Willecke F, Tiwari S, Rupprecht B, et al. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice. Thromb Haemost 2014; 112: 379-389.
2. Kapopara PR, von Felden J, Soehnlein O, et al. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury. Thromb Haemost 2014; 112: 1264-1276.
3. Kenagy RD, Hart CE, Stetler-Stevenson WG, et al. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 1997; 96: 3555-3560.
4. Caglayan E, Vantler M, Leppanen O, et al. Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cgamma 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo. J Am Coll Cardiol 2011; 57: 2527-2538.
5. Holy EW, Jakob P, Eickner T, et al. PI3K/p110alpha inhibition selectively interferes with arterial thrombosis and neointima formation, but not reendothelialization: potential implications for drug-eluting stent design. Eur Heart J 2014; 35: 808-820.
6. Borst O, Schmidt EM, Munzer P, et al. The serumand glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood 2012; 119: 251-261.
7. Yang M, Zheng J, Miao Y, et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscl Thromb Vasc Biol 2012; 32: 1675-1686.
8. Cheng J, Wang Y, Ma Y, et al. The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010; 107: 1265-1274.
9. BelAiba RS, Djordjevic T, Bonello S, et al. The serum-and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res 2006; 98: 828-836.
10. Borst O, Schaub M, Walker B, et al. Pivotal role of serum-and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Arterioscl Thromb Vasc Biol 2015; 35: 547-557.
11. Lang F, Munzer P, Gawaz M, et al. Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets. Thromb Haemost 2013; 110: 925-930.
12. Walker B, Schmid E, Russo A, et al. Impact of the serum-and glucocorticoid-inducible kinase 1 on platelet dense granule biogenesis and secretion. J Thromb Haemost 2015; 13: 1325-1334.
13. Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, et al. Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol Cell Pphysiol 2010; 298: C993-1005.
14. Zhang W, Halligan KE, Zhang X, et al. Orai1-mediated I (CRAC) is essential for neointima formation after vascular injury. Circ Res 2011; 109: 534-542.
15. Aubart FC, Sassi Y, Coulombe A, et al. RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Mol Therapy 2009; 17: 455-462.
16. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscl Thromb Vasc Biol 1997; 17: 2238-2244.
17. Furgeson SB, Simpson PA, Park I, et al. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res 2010; 86: 274-282.
18. Yoshida T, Yamashita M, Horimai C, et al. Smooth muscle-selective inhibition of nuclear factor-kappaB attenuates smooth muscle phenotypic switching and neointima formation following vascular injury. J Am Heart Assoc 2013; 2: e000230.
19. Schonberger T, Siegel-Axel D, Bussl R, et al. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/-mice. Cardiovasc Res 2008; 80: 131-137.
20. Zhong W, Oguljahan B, Xiao Y, et al. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of beta-catenin dynamics. Cell Signal 2014; 26: 2765-2772.
21. Sun JY, Li C, Shen ZX, et al. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NFkappaB Pathways. Arterioscl Thromb Vasc Biol 2016; 36: 874-885.
22. Eylenstein A, Schmidt S, Gu S, et al. Transcription factor NF-kappaB regulates expression of poreforming Ca2+ channel unit, Orai1, and its activator, STIM1, to control Ca2+ entry and affect cellular functions. J Biol Chem 2012; 287: 2719-2730.
23. Cercek B, Yamashita M, Dimayuga P, et al. Nuclear factor-kappaB activity and arterial response to balloon injury. Atherosclerosis 1997; 131: 59-66.